Skip to content

APOTEEK WINDEY: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTEEK WINDEY

BE 0446.190.201
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€40,777
2024 · €48,501-€7,724
Equity
€230,886
2024 · €190,109+€40,777
Cash
€131,707
2024 · €117,945+€13,762
Balance sheet total
€306,023
2024 · €288,393+€17,630

Largest movements

2024 to 2025
Assets
  • Cash +€13,762

    up €13,762 (+11.7%), from €117,945 to €131,707

    mainly Net result for the year (+€40,777) and Trade debts (+€5,439)

  • Stocks and contracts +€3,761

    up €3,761 (+4.5%), from €84,085 to €87,846

  • Receivables within one year +€3,478

    up €3,478 (+5.8%), from €59,598 to €63,076

    of which Trade receivables: +€3,706

Equity and liabilities
  • Reserves +€40,777

    up €40,777 (+31.8%), from €128,109 to €168,886

    of which Distributable reserves: +€40,777

  • Other debts -€14,924

    down €14,924 (-81.7%), from €18,259 to €3,335

  • Tax, wage and social debts -€7,241

    down €7,241 (-76.5%), from €9,468 to €2,227

    of which Taxes: -€7,296

  • Trade debts +€5,439

    up €5,439 (+9.1%), from €59,965 to €65,404

  • Current portion of long-term debt -€4,971

    no longer reported in 2025 (was €4,971)

Income statement
  • Staff costs +€6,510

    up €6,510 (+87.1%), from €7,472 to €13,982

  • Gross operating margin -€4,223

    down €4,223 (-4.7%), from €90,322 to €86,099

  • Taxes -€3,419

    down €3,419 (-18.3%), from €18,718 to €15,298

  • Other operating charges -€1,247

    down €1,247 (-51.1%), from €2,442 to €1,195

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €48,501
Gross operating margin -€4,223
Staff costs -€6,510
Depreciation -€713
Other operating charges +€1,247
Financial income -€302
Financial charges -€641
Taxes +€3,419
Result 2025 €40,777
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€19,933
Investment -€1,199
Financing -€4,971
Cash 2024 €117,945
Net result for the year +€40,777
Depreciation +€3,712
Stocks and contracts -€3,761
Receivables within one year -€3,478
Deferred charges and accrued income +€859
Trade debts +€5,439
Tax, wage and social debts -€7,241
Other debts -€14,924
Accrued charges and deferred income -€1,450
Investment in fixed assets (net) -€1,199
Current portion of long-term debt -€4,971
Cash 2025 €131,707
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €288,393 €306,023 +€17,630 +6.1%
Fixed assets 21/28 €21,056 €18,543 -€2,512 -11.9%
Tangible fixed assets 22/27 €21,056 €18,543 -€2,512 -11.9%
Land and buildings 22 €16,891 €14,058 -€2,832 -16.8%
Plant, machinery and equipment 23 €4,165 €4,485 +€320 +7.7%
Current assets 29/58 €267,337 €287,479 +€20,142 +7.5%
Stocks and contracts in progress 3 €84,085 €87,846 +€3,761 +4.5%
Stocks 30/36 €84,085 €87,846 +€3,761 +4.5%
Amounts receivable within one year 40/41 €59,598 €63,076 +€3,478 +5.8%
Trade receivables 40 €58,812 €62,518 +€3,706 +6.3%
Other amounts receivable 41 €786 €558 -€228 -29.0%
Current investments 50/53 €2,681 €2,681 = 0.0%
Cash at bank and in hand 54/58 €117,945 €131,707 +€13,762 +11.7%
Deferred charges and accrued income 490/1 €3,028 €2,169 -€859 -28.4%
Total equity and liabilities 10/49 €288,393 €306,023 +€17,630 +6.1%
Equity 10/15 €190,109 €230,886 +€40,777 +21.4%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €128,109 €168,886 +€40,777 +31.8%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €121,909 €162,686 +€40,777 +33.4%
Amounts payable 17/49 €98,284 €75,137 -€23,147 -23.6%
Amounts payable within one year 42/48 €92,662 €70,965 -€21,697 -23.4%
Current portion of amounts payable after more than one year 42 €4,971 - -€4,971
Trade debts 44 €59,965 €65,404 +€5,439 +9.1%
Suppliers 440/4 €59,965 €65,404 +€5,439 +9.1%
Taxes, remuneration and social security 45 €9,468 €2,227 -€7,241 -76.5%
Taxes 450/3 €7,710 €414 -€7,296 -94.6%
Remuneration and social security 454/9 €1,758 €1,813 +€55 +3.1%
Other amounts payable 47/48 €18,259 €3,335 -€14,924 -81.7%
Accrued charges and deferred income 492/3 €5,622 €4,172 -€1,450 -25.8%
Remuneration, social security and pensions 62 €7,472 €13,982 +€6,510 +87.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,999 €3,712 +€713 +23.8%
Other operating charges 640/8 €2,442 €1,195 -€1,247 -51.1%
Gross operating margin 9900 €90,322 €86,099 -€4,223 -4.7%
Operating profit (loss) 9901 €77,410 €67,210 -€10,200 -13.2%
Financial income 75/76B €653 €351 -€302 -46.2%
Recurring financial income 75 €653 €351 -€302 -46.2%
Financial charges 65/66B €10,844 €11,485 +€641 +5.9%
Recurring financial charges 65 €10,844 €11,485 +€641 +5.9%
Profit (loss) for the period before taxes 9903 €67,219 €56,076 -€11,143 -16.6%
Income taxes 67/77 €18,718 €15,298 -€3,419 -18.3%
Profit (loss) for the period 9904 €48,501 €40,777 -€7,724 -15.9%
Profit (loss) for the period to be appropriated 9905 €48,501 €40,777 -€7,724 -15.9%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.